All News Seikagaku Corporation

Equities

4548

JP3414000004

Delayed Japan Exchange Other stock markets 10:12:49 16/05/2024 am IST			5-day change	1st Jan Change
780 ^JPY	+0.52%		+4.86%	+1.97%

08/04	Ferring Pharmaceuticals Inc. Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603, in Lumbar Disc Herniation at ASIPP 2024	CI
2023	Seikagaku Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Seikagaku : Announces the Biologics License Application for SI-6603 Has Been Accepted for Filing by the U.S. FDA	14/05	PU
Seikagaku : Consolidated Financial Results for the Fiscal Year Ended March 31, 2024	13/05	PU
Seikagaku : Consolidated Financial Results (Summary) for Fiscal 2023(Year Ended March 31, 2024)	13/05	PU
Ferring Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603, in Lumbar Disc Herniation at ASIPP 2024	09/04	AQ
Seikagaku : Announces an Academic Conference Presentation on SI-6603 by Licensee Ferring Pharmaceuticals Inc.	09/04	PU
Ferring Pharmaceuticals Inc. Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603, in Lumbar Disc Herniation at ASIPP 2024	08/04	CI
Final dividend	28/03	FA
Seikagaku : Financial Results for the Second Quarter of Fiscal Year 2023	10/11	PU
Ex-dividend day for interim dividend	28/23/28	FA
Seikagaku : Consolidated Financial Results (Summary) for the First Three Months of Fiscal 2023 (Three-Month Period Ended June 30, 2023)	04/23/04	PU
Seikagaku : Financial Results for the First Quarter of Fiscal Year 2023	04/23/04	PU
Ferring Announces Positive Topline Phase 3 Results for SI-6603, an Investigational Treatment for Lumbar Disc Herniation	29/23/29	AQ
Seikagaku : Announces the Topline Results from a Phase III Clinical Study (Additional Study) in the U.S. for SI-6603, a Treatment for Lumbar Disc Herniation	26/23/26	PU
Seikagaku : Convocation Notice of the 77th Ordinary General Meeting of Shareholders	22/23/22	PU
Seikagaku : Convocation Notice of the 77th Ordinary General Meeting of Shareholders	19/23/19	PU
Seikagaku : Consolidated Financial Results (Summary) for Fiscal 2022(Year Ended March 31, 2023)	12/23/12	PU
Seikagaku Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	12/23/12	CI
Seikagaku : Financial Results for the Fiscal Year 2022	12/23/12	PU
Ex-dividend day for final dividend	30/23/30	FA
Seikagaku : Consolidated Financial Results for the Thrid Quarter of Fiscal year 2022	08/23/08	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Seikagaku Corporation

Equities

4548

JP3414000004

All News

Filters